本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PDS Biotechnology Corporation

0.2185
+0.00964.60%
盤前0.21860.0001+0.05%07:55 EDT
成交量:293.31萬
成交額:65.33萬
市值:1,219.57萬
市盈率:-0.34
高:0.2358
開:0.2075
低:0.2075
收:0.2089
52周最高:1.55
52周最低:0.1952
股本:5,581.57萬
流通股本:5,440.43萬
量比:1.41
換手率:5.39%
股息:- -
股息率:- -
每股收益(TTM):-0.6401
每股收益(LYR):-0.7437
淨資產收益率:-543.97%
總資產收益率:-70.59%
市淨率:-3.41
市盈率(LYR):-0.29

資料載入中...

公司資料

公司名字:
PDS Biotechnology Corporation
交易所:
NASDAQ
成立時間:
2005
員工人數:
21
公司地址:
303A College Road East,Princeton,New Jersey,United States
郵編:
08540
電話:
傳真:
- -
簡介:
PDS Biotechnology Corporation於2009年1月22日根據特拉華州法律成立。該公司是一家臨床階段的生物技術公司,專註於發現,開發和尋求商業化的新穎的以醫院為基礎的治療方案,能夠改變治療模式和危及生命的管理。

董事

名稱
職位
Frank Bedu Addo
Chief Executive Officer,Director and President
Stephen Glover
Chairman of the Board
Gregory Freitag
Independent Director
Ilian Iliev
Independent Director
Kamil Ali Jackson
Independent Director
Otis Brawley
Independent Director

股東

名稱
職位
Frank Bedu Addo
Chief Executive Officer,Director and President
Stephan Toutain
Chief Operating Officer
Lars Boesgaard
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Spencer Brown
Senior Vice President, General Counsel, Corporate Secretary, and Compliance Officer
Gregory L. Conn
Chief Scientific Officer
Kirk Shepard
Chief Medical Officer